April 15, 2025 - 18:44
PASADENA, Calif., April 15, 2025—Arrowhead Pharmaceuticals has announced the appointment of Daniel Apel as the new Chief Financial Officer, effective May 13, 2025. This transition comes as current CFO Ken Myszkowski prepares to retire after an impressive 16-year tenure with the company. Myszkowski has played a significant role in shaping the financial landscape of Arrowhead, and his contributions will be missed.
To ensure a smooth transition, Myszkowski will remain with the company in an advisory capacity, supporting Apel as he steps into his new role. Apel brings a wealth of experience and expertise to Arrowhead, having held various financial leadership positions in the biotechnology sector. His appointment is expected to bolster the company’s financial strategy as it continues to innovate in the pharmaceutical industry.
The leadership change marks a new chapter for Arrowhead, as it aims to enhance its operational efficiency and drive sustainable growth in the coming years.
June 24, 2025 - 08:49
Jensen Huang Initiates Stock Sales Under $865 Million StrategyNvidia`s CEO, Jensen Huang, has commenced the sale of the company`s stock as part of a strategic plan that permits him to divest up to $865 million worth of shares by the end of the year. This...
June 23, 2025 - 19:30
Fourth International Conference on Financing for Development: A Chance for ReformThe Fourth International Conference on Financing for Development (FFD4) is set to provide a pivotal platform for transforming financing mechanisms across the globe. This conference aims to address...
June 23, 2025 - 03:38
Understanding Financing for Development: A Global NecessityThe global community faces an urgent need for substantial financial resources to address pressing challenges. According to the United Nations, an additional $4 trillion is required annually to...
June 22, 2025 - 03:15
Trump Family Ventures into Smartphone Market, but Manufacturing in America UncertainPresident Trump`s family is set to launch a new smartphone, stirring interest and speculation in the tech industry. However, recent reports suggest that the device may not be manufactured in the...